CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
positron emission tomography +3 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01807117
NCT01807117N/ACompleted

Evaluation of PET-MRI in Initial Staging of High Grade Rectal Cancer Patients and in the Follow up of Colorectal Cancer Patients.

Case Comprehensive Cancer Center·interventional·Posted Mar 8, 2013·Updated May 18, 2021

In Brief

A clinical study evaluating positron emission tomography, computed tomography, and 2 other interventions for Recurrent Colon Cancer and 17 related conditions. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This pilot clinical trial studies positron emission tomography (PET)-magnetic resonance imaging (MRI) and PET-computed tomography (CT) as diagnostic imaging in patients with colon and/or rectal cancer. New diagnostic imaging procedures, such as PET-MRI, may help find and diagnose rectal cancer or recurrence of colorectal cancer

Study Details

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 8, 2013
Enrollment StartApr 1, 2013
Primary CompletionMar 5, 2014
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 13.3 years ago

Interventions

positron emission tomographyprocedure

Undergo fludeoxyglucose F 18 PET-CT and PET-MRI

computed tomographyprocedure

Undergo fludeoxyglucose F 18 PET-CT and PET-MRI

magnetic resonance imagingprocedure

Undergo fludeoxyglucose F 18 PET-CT and PET-MRI

fludeoxyglucose F 18radiation

Undergo fludeoxyglucose F 18 PET-CT and PET-MRI